1102 - MDS

  • Protocol Short Name and Number: RIC vs Hypometh for MDS, 1102
  • Protocol Long Name: A Multi-Center Biologic Assignment Trial Comparing Reduced Intensity Allogeneic Hematopoietic Cell Transplant to Hypomethylating Therapy or Best Supportive Care in Patients Aged 50-75 with Intermediate-2 and High Risk Myelodysplastic Syndrome
  • Protocol (PDF)
  • ICFs (PDF)
  • FAQs (PDF)
  • Key Personnel
    • BMT CTN # 1102 Co-Chair: Corey Cutler, MD, MPH, FRCP(C)
    • BMT CTN # 1102 Co-Chair: Ryotaro (Ryo) Nakamura, MD
    • BMT CTN # 1102 Protocol Officer: Wael Saber, MD, MS
    • BMT CTN # 1102 Protocol Coordinator: Kristy Applegate; bmtctn1102@emmes.com
  • Keywords: Myelodysplastic Syndrome, MDS, Allogeneic Transplant, Allo Transplant, Allo, Reduced Intensity Conditioning, RIC, Biologic Assignment, Quality of Life, QOL, Unrelated, Unrelated Donor